Diffusion-controlled drug release
ID: diffusion-controlled-drug-release
Diffusion-controlled drug release occurs when molecular transport down a concentration gradient controls the relevant release time scale. It is a mechanism defined for a particular material, geometry and environment, rather than a name for every slowly changing release curve. A classic theoretical treatment by T. Higuchi distinguishes several matrix and geometrical models.[ref]
Mechanism of Sustained-Action Medication. Theoretical Analysis of Rate of Release of Solid Drugs Dispersed in Solid Matrices by T. Higuchi. Original abstract and publication, pp. 1145–1149
A simple example is an initially uniform dissolved substance of concentration in a planar material, with constant diffusion coefficient . At early times, approximate the material as the half-space and impose a perfect sink condition in drug release, . Solving the diffusion equation givesFick's first law then gives outward mass flux of magnitudeThis derivation is for dissolved material under the stated boundary condition; it does not identify every square-root law with the same solid-particle matrix model.
For a finite layer of thickness releasing through one face, the early-time fraction is approximately . With illustrative and , the time scale is , and at the approximation gives . Extending it to would give , demonstrating its failure once the finite size matters. The initial mathematical singularity in likewise reflects idealized initial and boundary conditions.
A useful experimental check changes thickness while keeping material and boundary conditions comparable: this diffusion model predicts a time scale proportional to . Swelling, changing diffusivity, degradation or external transport can alter that scaling. A membrane used by the measurement apparatus can also limit transport, so observing a slow curve alone does not locate the controlling resistance inside the formulation.[ref]
Adaptive Perfusion: A Novel In Vitro Drug Release Testing Method for Complex Drug Products by the FDA. Technology Summary, limitations of passive membrane transport
New to topics? Read the docs here!